Federal Court Revives Landmark Fraud Case Against Big Pharma for Overcharging a Program Built to Protect America's Poorest Patients

US court revives fraud case against AbbVie, AstraZeneca, Novartis, and Sanofi over alleged 340B drug overcharges impacting low-income patients.